Grifols (ADR) (GRFS)
Builds plasma-derived therapies, diagnostics, and biologic supplies around an integrated plasma network.
$7.28
vs last close−0.16 (−2.15%)
Something off on this page? Send us feedback.
Next report
Nov 10, 26
in 48 days
EPS estimate
$0.30
Revenue estimate
$2.29B
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Jul '25Nov '25Feb '26May '26Jul '26Nov '26
Reported$0.24$0.13$0.19$0.21$0.29$0.17$0.25Pending
Estimate$0.23$0.15$0.23$0.24$0.29$0.16$0.27$0.30
Surprise+3.0%−10.4%−17.4%−12.8%−0.3%+7.3%−7.0%—
RevenueReportedEstimate
Feb '25May '25Jul '25Nov '25Feb '26May '26Jul '26Nov '26
Reported$2.06B$1.99B$2.17B$2.14B$2.34B$2.00B$2.13BPending
Estimate$2.03B$1.96B$2.20B$2.15B$2.34B$2.03B$2.17B$2.29B
Surprise+1.1%+1.7%−1.2%−0.6%−0.2%−1.4%−1.5%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Mar 2027 | $0.00 | — | — |
| Dec 2026 | $0.34 | — | — |
| Nov 2026 | $0.30 | — | — |
| Jul 2026 | $0.27 | $0.25 | −7.0% |
| May 2026 | $0.16 | $0.17 | +7.3% |
| Feb 2026 | $0.29 | $0.29 | −0.3% |
| Nov 2025 | $0.24 | $0.21 | −12.8% |
| Jul 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Jul 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Feb 2023 | |||
| Jul 2022 | |||
| May 2022 | $0.22 | — | — |
| Feb 2022 | |||
| Dec 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Jul 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Jul 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Jul 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Mar 2027 | $0.00 | — | — | $3.13B | — | — | — |
| Dec 2026 | $0.34 | — | — | $2.11B | — | — | — |
| Nov 10, 2026 | $0.30 | — | — | $2.29B | — | — | — |
| Jul 28, 2026 | $0.27 | $0.25 | −7.0% | $2.17B | $2.13B | −1.5% | +3.2% |
| May 7, 2026 | $0.16 | $0.17 | +7.3% | $2.03B | $2.00B | −1.4% | +0.5% |
| Feb 26, 2026 | $0.29 | $0.29 | −0.3% | $2.34B | $2.34B | −0.2% | −3.1% |
| Nov 4, 2025 | $0.24 | $0.21 | −12.8% | $2.15B | $2.14B | −0.6% | −2.2% |
| Jul 29, 2025 | |||||||
| May 12, 2025 | |||||||
| Feb 26, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Jul 30, 2024 | |||||||
| May 14, 2024 | |||||||
| Feb 29, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Jul 27, 2023 | |||||||
| May 9, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Feb 27, 2023 | |||||||
| Jul 28, 2022 | |||||||
| May 5, 2022 | $0.22 | — | — | $3.00B | — | — | — |
| Feb 28, 2022 | |||||||
| Dec 30, 2021 | |||||||
| Jul 29, 2021 | |||||||
| May 4, 2021 | |||||||
| Feb 26, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Jul 30, 2020 | |||||||
| Apr 21, 2020 | |||||||
| Feb 27, 2020 | |||||||
| Oct 29, 2019 | |||||||
| Jul 31, 2019 | |||||||
| May 7, 2019 | |||||||
| Feb 28, 2019 | |||||||
| Nov 5, 2018 | |||||||
| Jul 27, 2018 | |||||||
| May 3, 2018 | |||||||
| Feb 28, 2018 | |||||||
| Nov 2, 2017 | |||||||
| Jul 28, 2017 | |||||||
| May 3, 2017 | |||||||
| Feb 28, 2017 | |||||||
| Nov 8, 2016 | |||||||
| Jul 28, 2016 | |||||||
| May 5, 2016 | |||||||
| Feb 29, 2016 | |||||||
| Nov 4, 2015 | |||||||
| Jul 30, 2015 |
